| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 06/13/2006 | US7060464 Peptides conferring environmental stress resistance and fusion proteins including said peptides |
| 06/13/2006 | US7060284 Polypeptides and polynucleotides for enhancing immune reactivity to HER-2 protein |
| 06/13/2006 | US7060279 Compositions and methods for dendritic cell-based immunotherapy |
| 06/13/2006 | US7060265 Cloning and recombinant production of polistinae venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon |
| 06/08/2006 | WO2006059105A2 Non-cytotoxic Protein Conjugates |
| 06/08/2006 | WO2006059093A2 Fusion proteins |
| 06/08/2006 | WO2003076571A3 Cancer-linked gene as target for chemotherapy |
| 06/08/2006 | US20060122374 Albumin-fused anti-angiogenesis peptides |
| 06/08/2006 | US20060122370 Specific binding agents of human angiopoietin-2 |
| 06/08/2006 | US20060121546 For detection of caspases, trypsin and tryptase; comprises luciferase and amino-modified aminoluciferin or a carboxy-terminal protected derivative; solid phase synthesis |
| 06/08/2006 | US20060121514 Prostacyclin-stimulating Factor-2 |
| 06/08/2006 | US20060121025 VEGF-related protein |
| 06/08/2006 | CA2595115A1 Fusion proteins for treating, preventing or ameliorating pain |
| 06/08/2006 | CA2589802A1 Plad domain peptides with increased serum half life due to conjugation to domain antibodies |
| 06/08/2006 | CA2588292A1 Non-cytotoxic protein conjugates |
| 06/08/2006 | CA2489940A1 Relay vaccine |
| 06/07/2006 | EP1666594A2 Polypeptide, nucleic acid encoding it, and their use for the diagnosis of cancer |
| 06/07/2006 | EP1666499A2 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production |
| 06/07/2006 | EP1666498A2 Soluble CTLA4 molecules, compositions comprising said molecules and uses thereof |
| 06/07/2006 | EP1666497A2 Polypeptide, nucleic acid encoding it, and their use for the diagnosis of cancer |
| 06/07/2006 | EP1666493A1 Secreted and transmembrane polypeptides and nucleic acids ancoding the same |
| 06/07/2006 | EP1666492A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/07/2006 | EP1666491A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/07/2006 | EP1664124A2 Product comprising a c4bp core protein and a monomeric antigen, and its use |
| 06/07/2006 | EP1364023B1 Gene highly expressed in cartilage tissues |
| 06/07/2006 | EP1309690B1 Mfq-111, a human gtpase like protein |
| 06/07/2006 | EP1268514B1 Methods for purifying highly anionic proteins |
| 06/07/2006 | EP1254234B1 Haemophilus influenza outer membrane protein and use thereof in vaccination |
| 06/07/2006 | EP1107794B1 Therapeutic compositions for the treatment of mucus hypersecretion |
| 06/07/2006 | EP0939767B1 Porcine factor viii and hybrids thereof |
| 06/07/2006 | EP0813538B1 Compositions and methods for the treatment and diagnosis of immune disorders |
| 06/07/2006 | EP0719335B1 Hybrid toxin |
| 06/07/2006 | CN1781947A Modified peptides as therapeutic agents |
| 06/07/2006 | CN1781946A Modified peptides as therapeutic agents |
| 06/07/2006 | CN1781945A Modified peptides as therapeutic agents |
| 06/06/2006 | US7057017 Human dickkopf-related protein and nucleic acid molecules and uses therefor |
| 06/06/2006 | US7056701 Hormone and albumin fusion protein |
| 06/06/2006 | CA2120153C Recombinant immunotoxins |
| 06/01/2006 | WO2005114220A3 Compositions, kits, and methods for calibration in mass spectrometry |
| 06/01/2006 | WO2005047478A3 Compositions and methods for regulation of tumor necrosis factor-alpha |
| 06/01/2006 | US20060117412 Stable plastid transformation and expression vector for transferring target nucleotide sequences into plants for mass production of affordable vaccines and pharmaceutical agents |
| 06/01/2006 | US20060115874 Enrichment method for variant proteins with altered binding properties |
| 06/01/2006 | US20060115491 Vaccine delivery; attaching immunogenic determinant of heterologous polypeptide biodrug to the peptidoglycan microparticle on cell wall of a Gram-positive bacterium; improve the binding by treating the cell wall with acid solution to remove protein, lipotechoic, carbohydrates |
| 06/01/2006 | US20060115490 vaccines, immunogenic compositions; diagnostics, enzymatic studies and targets for antibiotics; for treating Staphylococcus aureus infection |
| 06/01/2006 | DE19910102B4 Proteinkonjugate, Verfahren, Vektoren, Proteine und DNA zu deren Herstellung, deren Verwendung, sowie Arzneimittel und Impfstoffe mit einem Gehalt derselben Protein conjugates, methods, vectors, proteins, and DNA for their preparation, their use, as well as drugs and vaccines containing the same |
| 06/01/2006 | CA2589487A1 Means and methods for detecting methylated dna |
| 06/01/2006 | CA2589164A1 Production of proteins |
| 05/31/2006 | EP1661910A1 Peptides capable of binding to titanium, silver and silicone |
| 05/31/2006 | EP1660660A2 Polypeptides of streptococcus pyogenes |
| 05/31/2006 | EP1660650A2 Improved sso7-polymerase conjugate proteins |
| 05/31/2006 | EP1660539A2 Compounds comprising lpa |
| 05/31/2006 | EP1470229B1 Protein tag comprising a biotinylation domain and method for increasing solubility and determining folding state |
| 05/31/2006 | EP1268798B1 Anti-angiogenic properties of vascostatin and fragments or variants thereof |
| 05/31/2006 | EP1198580B1 Scleroprotein of an adeno-associated virus with modified chromatographic properties, the production thereof and use of the same |
| 05/31/2006 | CN1780641A Single chain antigen-binding polypeptides for polymer conjugation |
| 05/31/2006 | CN1778930A Fusion gene of provocative organ anti-Coccidium tenellum infection and its coding protein and use thereof |
| 05/31/2006 | CN1778929A Recombinant human platelet auxin/dry cell factor fusion protein and preparation thereof |
| 05/30/2006 | US7053266 Chimeric cry1E δendotoxin and methods of controlling insects |
| 05/30/2006 | US7053184 Expression vector coding polypeptide with thrombin proteolytic sequences; for use in evaluating ligand binding and signal transduction |
| 05/30/2006 | US7053179 Inhibits hiv infection of cells |
| 05/30/2006 | US7053062 Compositions and methods for inducing gene expression |
| 05/30/2006 | US7053042 Activation of peptide prodrugs by hK2 |
| 05/30/2006 | US7052896 Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them |
| 05/30/2006 | US7052689 Preventing viral replication in cells; obtain cells, incubate with viricide, monitor cells for reduced viral activity |
| 05/26/2006 | WO2006054096A2 Soluble bifunctional proteins |
| 05/26/2006 | WO2006053613A2 Skin care composition comprising fusion polypeptide composition |
| 05/25/2006 | US20060110800 Testis-specific receptor |
| 05/25/2006 | US20060110730 Methods and compositions for regulation and manipulation of steroidogenesis |
| 05/25/2006 | US20060110410 Recombinant toxin fragments |
| 05/25/2006 | US20060110409 Targeted agents for nerve regeneration |
| 05/25/2006 | US20060110400 Immunogenic conjugates |
| 05/24/2006 | EP1659179A2 Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccination |
| 05/24/2006 | EP1659178A2 Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccination |
| 05/24/2006 | EP1659177A2 Secreted and transmembrane polypeptides and nucleic acids ancoding the same |
| 05/24/2006 | EP1659131A2 Polypeptides and nucleic acids encoding the same |
| 05/24/2006 | EP1227848B1 Method for linking molecular substances |
| 05/24/2006 | EP1141305B1 Chimeric gene encoding the antigenic determinants of four proteins of l. infantum |
| 05/24/2006 | EP1121382B1 Interferon-beta fusion proteins and uses |
| 05/24/2006 | EP1015585B1 Tie ligand homologues |
| 05/24/2006 | EP1002075B1 Adipocyte-specific protein homologs |
| 05/24/2006 | EP0907733B1 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production |
| 05/24/2006 | EP0892809B1 Fhit proteins and nucleic acids and methods based thereon |
| 05/24/2006 | CN1777439A Somatostatin vectors |
| 05/24/2006 | CN1775946A Enhanced virus-mediated DNA transfer |
| 05/24/2006 | CN1257187C Calreticulin-tumor necrosis factor correlated apoptosis inducing ligand fusion protein and its prearation and use |
| 05/23/2006 | US7049286 Insulin conjugates and methods of use thereof |
| 05/23/2006 | US7049136 Redirection of cellular immunity by receptor chimeras |
| 05/23/2006 | US7048949 with target membrane or other hydrophobic proteins (G protein coupled receptor protein) or membrane fragments to form soluble nanoscale particles which preserve their native structure and function; allows manipulation of incorporated proteins in solution or on solid supports |
| 05/23/2006 | CA2335305C A bioluminescence resonance energy transfer (bret) system and its use |
| 05/18/2006 | WO2006051944A1 Fluorescent protein |
| 05/18/2006 | WO2006050977A1 Recombinant trl-md-2 fusion proteins |
| 05/18/2006 | WO2006015297A3 Methods of treating type i diabetes by blocking vegf-mediated activity |
| 05/18/2006 | US20060105947 Novel chimeric analgesic peptides |
| 05/18/2006 | US20060105429 Nucleic acid encoding protein which comprises hormone and has higher plasma stability; maintains biological activity for prolonged period in body |
| 05/18/2006 | US20060104899 Production and use of novel peptide-based agents for use with bi-specific antibodies |
| 05/18/2006 | CA2586811A1 Peptides derived from maurocalcine used as vectors for intracellular addressing of molecules of interest |
| 05/17/2006 | EP1657257A1 Recombinant TLR-MD-2 fusion proteins |
| 05/17/2006 | EP1657256A2 Compositions and methods for the treatment of tumor |
| 05/17/2006 | EP1656952A2 Polymer conjugates of interferon beta-1A and uses thereof |
| 05/17/2006 | EP1656950A1 Immunotoxins directed against CD33 related surface antigens |